Table 2. Demographic characteristics of major SARS-CoV-2 variants detected during the study period (n = 882).

	BA.2.10*	BA.2.38*	BA.2.75*	BA.5*	BQ.1*	XBB*	Grand total
Gender-wise distribution, p-value = 0.088
Male	22 (68.75%)	19 (42.22%)	311 (53.53%)	15 (40.54%)	10 (66.67%)	98 (56.98%)	475 (53.85%)
Female	10 (31.25%)	26 (57.78%)	270 (46.47%)	22 (59.46%)	05 (33.33%)	74 (43.02%)	407 (46.15%)
Median age, H (5) = 12.343, p-value = 0.030
	29.5 (IQR: 20.5 – 43.0)	38.0 (IQR: 29.0 – 58.0)	38.0 (IQR: 28.0 – 57.0)	38.0 (IQR: 31.0 – 59.0)	55.0 (IQR: 41.0 – 71.0)	38.5 (IQR: 28.5 – 59.0)
Age-wise distribution
0 to <10	01 (3.13%)	00 (00%)	11 (1.89%)	01 (2.70%)	00 (00%)	03 (1.74%)	16 (1.81%)
10 to <20	07 (21.88%)	04 (8.89%)	25 (4.30%)	00 (00%)	00 (00%)	11 (6.40%)	47 (5.33%)
20 to <30	08 (25.00%)	08 (17.78%)	133 (22.89%)	06 (16.22%)	01 (6.67%)	32 (18.60%)	188 (21.32%)
30 to <40	04 (12.50%)	11 (24.44%)	140 (24.10%)	13 (35.14%)	02 (13.33%)	42 (24.42%)	212 (24.04%)
40 to <50	05 (15.63%)	06 (13.33%)	53 (9.12%)	03 (8.11%)	04 (26.67%)	21 (12.21%)	92 (10.43%)
50 to <60	01 (3.13%)	05 (11.11%)	86 (14.80%)	07 (18.92%)	02 (13.33%)	22 (12.79%)	123 (13.95%)
60 to <70	05 (15.63%)	04 (8.89%)	64 (11.02%)	05 (13.51%)	02 (13.33%)	18 (10.47%)	98 (11.11%)
70 to <80	01 (3.13%)	06 (13.33%)	48 (8.26%)	02 (5.41%)	03 (20.00%)	18 (10.47%)	78 (8.84%)
80 to <90	00 (00%)	01 (2.22%)	21 (3.61%)	00 (00%)	01 (6.67%)	05 (2.91%)	28 (3.17%)